All In Biotech

Drug Trial Radar · NCT02216357

Trial to Determine the Safety of Oral Ifetroban in Patients With a History of Aspirin Exacerbated Respiratory Disease

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Determine the Safety of Oral Ifetroban in Patients With a History of Aspirin Exacerbated Respiratory Disease

Last checked: Nov 19, 2026Latest source record: May 15, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

19

Actual

Start

Aug 2014

Primary completion

Jan 2016

Study completion Jan 2016

Sponsor

Lead sponsor
Cumberland PharmaceuticalsIndustry
Sponsor type
Industry
First posted
Aug 13, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of the study is to determine the safety of oral ifetroban compared to placebo as measured by a \> 20% decrease in FEV1 compared to baseline following a dose of Investigational Medicinal Product (IMP) (Study Day 1 or 2) prior to initiation of the aspirin challenge.

Conditions

  • Aspirin Exacerbated Respiratory Disease (AERD)

Interventions

  • Ifetroban, Oral CapsuleDrug

  • Placebo, Oral CapsuleDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of Patients Who Experience a ≥ 20% Decrease in Forced Expiratory Volume in One Second (FEV1) Compared to Baseline Following a Dose of Investigational Medicinal Product (IMP) (Study Day 1 or 2) Prior to Initiation of the Aspirin ChallengeTime frame: Study Day 2

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Scripps Clinic

    San Diego, California

  • Kansas City Allergy and Asthma Associates, PA.

    Overland Park, Kansas

  • Allergy & Asthma Consultants of Rockland & Bergen

    West Nyack, New York

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.